Compagnie Lombard Odier S Cm A Athira Pharma, Inc. Transaction History
Compagnie Lombard Odier S Cm A
- $7.73 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding ATHA
# of Institutions
60Shares Held
18.7MCall Options Held
17.2KPut Options Held
800-
Perceptive Advisors LLC New York, NY5.4MShares$1.46 Million0.11% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.78MShares$749,4881.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$420,2950.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$403,0530.05% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$403,0530.87% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $10.2M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...